Physician profile
Pradeep Simlote
NPI 1992811806
$686.03
in general payments reported to CMS, 2019-2025
10 companies · $235 in 2025
The $235 reported for 2025 was less than what a typical Allergy & Immunology provider received nationally (typical 2025 total: $1,138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $141 · 2020: $44.84 · 2022: $63.81 · 2023: $127 · 2024: $73.61 · 2025: $235.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $436.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $436.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $177.39 | 2020-2025 | Tezspire, Fasenra |
| Genentech USA, INC. | $167.52 | 2020-2025 | Xolair |
| Optinose US, INC. | $118.74 | 2019 | |
| Genzyme Corporation | $82.28 | 2019-2024 | |
| Regeneron Healthcare Solutions, INC. | $31.54 | 2023 | Dupixent |
| Amgen INC. | $28.95 | 2022-2023 | Tezspire |
| Biocryst US Sales Co., LLC | $25.68 | 2023 | Orladeyo |
| Aimmune Therapeutics, INC. | $21.12 | 2022 | |
| Glaxosmithkline, LLC. | $17.10 | 2022 | |
| Greer Laboratories, INC. | $15.71 | 2023 | Oralair |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pradeep Simlote listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.